Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine.
Miriam N Mikhail LetteDiana PaezLawrence N ShulmanMathias GuckenbergerJean-Yves DouillardWim J G OyenFrancesco GiammarileVenkatesh RangarajanMichelle S GinsbergOlivier PelletZhongxing LiaoMay Abdel WahabPublished in: JCO global oncology (2022)
Lung cancer is the number one cancer killer worldwide. The essential role that medical imaging and nuclear medicine play in early diagnosis and disease staging cannot be overstated, pivotal in selecting the many patients for whom measurably improved outcomes are attainable. Prevention synergized with patient-centered, compassionate, high-quality lung cancer management provision mandate that strategic population-based planning, including universal health coverage strategies, should extend well beyond the scope of disease prevention to include both curative and noncurative treatment options for the millions afflicted with lung cancer.
Keyphrases
- healthcare
- end stage renal disease
- prognostic factors
- newly diagnosed
- public health
- ejection fraction
- chronic kidney disease
- high resolution
- mental health
- lymph node
- squamous cell carcinoma
- artificial intelligence
- rectal cancer
- adipose tissue
- patient reported outcomes
- pet ct
- photodynamic therapy
- lymph node metastasis